Product Description
Empagliflozin 25mg/Linagliptin 5mg tablets, marketed as Glyxambi, are a combination medication used to treat type 2 diabetes.
Empagliflozin and linagliptin work together to lower blood sugar levels in individuals with type 2 diabetes
Empagliflozin:
Acts on the kidneys to block the reabsorption of glucose, leading to its excretion in the urine..
Linagliptin:
Increases insulin secretion from the pancreas and reduces the production of glucose by the liver.